
News|Videos|May 25, 2023
Changing the Paradigms of How We Think About Depression
Author(s)Greg Mattingly, MD
Check out this review of the 2023 APA Annual Meeting presentation on the efficacy and safety of repeat treatment courses using novel medicine, zuranolone.
Advertisement
CONFERENCE REPORTER
Greg Mattingly, MD, shares a review of the 2023 APA Annual Meeting presentation that covered long term results of the year long study on zuranolone in major depressive disorder.
Dr Mattingly is an associate clinical professor at Washington University School of Medicine, and is a physician and principal investigator in clinical trials for Midwest Research Group.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Repurposing Dopamine Agonist Pramipexole for Disabling Anhedonia
2
When Treatment-Resistant Depression Means Mismatched: Rethinking Difficult-to-Treat Depression
3
Brain Trust: Anita H. Clayton, MD, on Diagnosing and Treating Sexual Dysfunction
4
The Year So Far in GLP-1s: What Psychiatric Clinicians Need to Know
5











